Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Luger

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Allergy|November 3, 2010
The novel protease inhibitor SRD441 ointment is not effective in the treatment of adult subjects with atopic dermatitis: results of a randomized, vehicle-controlled studyR Foelster Holst, S Reitamo, R Yankova, et al.
Archives of Dermatological Research|April 7, 2016
The German National Program on Psoriasis Health Care 2005-2015: results and experiencesM Augustin, L Eissing, A Langenbruch, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 13, 2016
Quality of life and patient benefit following transition from methotrexate to ustekinumab in psoriasisM Augustin, C Blome, C Paul, et al.
The British Journal of Dermatology|October 15, 2013
Transition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT)C Paul, L Puig, K Kragballe, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 28, 2019
Examining the association between pruritus and quality of life in patients with atopic dermatitis treated with crisaboroleS Ständer, G Yosipovitch, A G Bushmakin, et al.
The British Journal of Dermatology|October 15, 2013
One-year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate-to-severe plaque psoriasisK Reich, L Puig, C Paul, et al.
The British Journal of Dermatology|July 8, 2015
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trialsK A Papp, M A Menter, M Abe, et al.
The British Journal of Dermatology|February 3, 2009
Ichthyosis vulgaris: novel FLG mutations in the German population and high presence of CD1a+ cells in the epidermis of the atopic subgroupV Oji, N Seller, A Sandilands, et al.
The British Journal of Dermatology|April 16, 2003
International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategiesC Ellis, T Luger, D Abeck, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 5, 2005
Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors: position statement of the European Dermatology ForumJ Ring, J Barker, H Behrendt, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Allergy|November 3, 2010
The novel protease inhibitor SRD441 ointment is not effective in the treatment of adult subjects with atopic dermatitis: results of a randomized, vehicle-controlled studyR Foelster Holst, S Reitamo, R Yankova, et al.
Archives of Dermatological Research|April 7, 2016
The German National Program on Psoriasis Health Care 2005-2015: results and experiencesM Augustin, L Eissing, A Langenbruch, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 13, 2016
Quality of life and patient benefit following transition from methotrexate to ustekinumab in psoriasisM Augustin, C Blome, C Paul, et al.
The British Journal of Dermatology|October 15, 2013
Transition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT)C Paul, L Puig, K Kragballe, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 28, 2019
Examining the association between pruritus and quality of life in patients with atopic dermatitis treated with crisaboroleS Ständer, G Yosipovitch, A G Bushmakin, et al.
The British Journal of Dermatology|October 15, 2013
One-year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate-to-severe plaque psoriasisK Reich, L Puig, C Paul, et al.
The British Journal of Dermatology|July 8, 2015
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trialsK A Papp, M A Menter, M Abe, et al.
The British Journal of Dermatology|February 3, 2009
Ichthyosis vulgaris: novel FLG mutations in the German population and high presence of CD1a+ cells in the epidermis of the atopic subgroupV Oji, N Seller, A Sandilands, et al.
The British Journal of Dermatology|April 16, 2003
International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategiesC Ellis, T Luger, D Abeck, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 5, 2005
Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors: position statement of the European Dermatology ForumJ Ring, J Barker, H Behrendt, et al.
Pageof 11